Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Cortellis Drugs to Watch in 2020 report

Cortellis Drugs to Watch in 2020 report

The three from this year’s list are: Valrox, which if approved, would become the first gene therapy for any form of haemophilia; Inclisiran, from The Medicines Company, which could become ... 8. Inclisiran from The Medicines Company (now a Novartis

Novartis plans inclisiran trial in the UK

Novartis plans inclisiran trial in the UK The announcement was made on the same day that the company officially opened its new headquarters in White City, London. ... Novartis acquired inclisiran from The Medicines Company, after a completing a $9.7bn takeover of the company.

Cosentyx, Entresto drive topline growth for Novartis in Q4

Cosentyx, Entresto drive topline growth for Novartis in Q4 According to the company, the momentum of the neprilysin inhibitor was driven by a higher demand in ambulatory settings. ... These new drugs are expected to continue to drive growth into 2020 – newly acquired cholesterol drug inclisiran, gained from

Novartis links up with NHS for speedy access to cholesterol drug inclisiran

Novartis links up with NHS for speedy access to cholesterol drug inclisiran Novartis gained inclisiran from its $9.7bn acquisition of the drug's developer The Medicines Company, which completed  last week. ... watchdog NICE once it receives approval from the European Medicines Agency (EMA).

Novartis picks up inclisiran after completion of MedCo acquisition

Novartis picks up inclisiran after completion of MedCo acquisition If approved could become blockbuster cholesterol treatment. Novartis has added potential blockbuster cholesterol treatment inclisiran to its pipeline following the completion of its $9.7bn acquisition of The Medicines Company. . ... 2021. “Acquiring

1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics